BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 24474430)

  • 21. Impact of previous antibiotic therapy on outcome of Gram-negative severe sepsis.
    Johnson MT; Reichley R; Hoppe-Bauer J; Dunne WM; Micek S; Kollef M
    Crit Care Med; 2011 Aug; 39(8):1859-65. PubMed ID: 21499086
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Using the number needed to treat to assess appropriate antimicrobial therapy as a determinant of outcome in severe sepsis and septic shock.
    Vazquez-Guillamet C; Scolari M; Zilberberg MD; Shorr AF; Micek ST; Kollef M
    Crit Care Med; 2014 Nov; 42(11):2342-9. PubMed ID: 25072764
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact and pattern of gram-negative bacteraemia during 6 y at a large university hospital.
    Harbarth S; Rohner P; Auckenthaler R; Safran E; Sudre P; Pittet D
    Scand J Infect Dis; 1999; 31(2):163-8. PubMed ID: 10447326
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bacteraemia due to multidrug-resistant Gram-negative bacilli in cancer patients: risk factors, antibiotic therapy and outcomes.
    Gudiol C; Tubau F; Calatayud L; Garcia-Vidal C; Cisnal M; Sánchez-Ortega I; Duarte R; Calvo M; Carratalà J
    J Antimicrob Chemother; 2011 Mar; 66(3):657-63. PubMed ID: 21193475
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy and safety of low-dose colistin in the treatment for infections caused by multidrug-resistant gram-negative bacteria.
    Zaidi ST; Al Omran S; Al Aithan AS; Al Sultan M
    J Clin Pharm Ther; 2014 Jun; 39(3):272-6. PubMed ID: 24593154
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization and anti-microbial susceptibility of gram-negative bacteria isolated from bloodstream infections of cancer patients on chemotherapy in Pakistan.
    Saghir S; Faiz M; Saleem M; Younus A; Aziz H
    Indian J Med Microbiol; 2009; 27(4):341-7. PubMed ID: 19736404
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prolonged infusion antibiotics for suspected gram-negative infections in the ICU: a before-after study.
    Arnold HM; Hollands JM; Skrupky LP; Smith JR; Juang PH; Hampton NB; McCormick S; Reichley RM; Hoban A; Hoffmann J; Micek ST; Kollef MH
    Ann Pharmacother; 2013 Feb; 47(2):170-80. PubMed ID: 23341160
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cefepime therapy for monomicrobial bacteremia caused by cefepime-susceptible extended-spectrum beta-lactamase-producing Enterobacteriaceae: MIC matters.
    Lee NY; Lee CC; Huang WH; Tsui KC; Hsueh PR; Ko WC
    Clin Infect Dis; 2013 Feb; 56(4):488-95. PubMed ID: 23090931
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of antibiotic resistance and of adequate empirical antibiotic treatment in the prognosis of patients with Escherichia coli bacteraemia.
    Peralta G; Sánchez MB; Garrido JC; De Benito I; Cano ME; Martínez-Martínez L; Roiz MP
    J Antimicrob Chemother; 2007 Oct; 60(4):855-63. PubMed ID: 17644532
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Failure of current cefepime breakpoints to predict clinical outcomes of bacteremia caused by gram-negative organisms.
    Bhat SV; Peleg AY; Lodise TP; Shutt KA; Capitano B; Potoski BA; Paterson DL
    Antimicrob Agents Chemother; 2007 Dec; 51(12):4390-5. PubMed ID: 17938179
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gram-negative bacteraemia; a multi-centre prospective evaluation of empiric antibiotic therapy and outcome in English acute hospitals.
    Fitzpatrick JM; Biswas JS; Edgeworth JD; Islam J; Jenkins N; Judge R; Lavery AJ; Melzer M; Morris-Jones S; Nsutebu EF; Peters J; Pillay DG; Pink F; Price JR; Scarborough M; Thwaites GE; Tilley R; Walker AS; Llewelyn MJ;
    Clin Microbiol Infect; 2016 Mar; 22(3):244-51. PubMed ID: 26577143
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Factors influencing mortality in abdominal solid organ transplant recipients with multidrug-resistant gram-negative bacteremia.
    Qiao B; Wu J; Wan Q; Zhang S; Ye Q
    BMC Infect Dis; 2017 Feb; 17(1):171. PubMed ID: 28241746
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risk factors for carbapenem resistant bacteraemia and mortality due to gram negative bacteraemia in a developing country.
    Kalam K; Qamar F; Kumar S; Ali S; Baqi S
    J Pak Med Assoc; 2014 May; 64(5):530-6. PubMed ID: 25272538
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antibiotic-resistant Gram-negative bacteremia in pediatric oncology patients--risk factors and outcomes.
    Haeusler GM; Mechinaud F; Daley AJ; Starr M; Shann F; Connell TG; Bryant PA; Donath S; Curtis N
    Pediatr Infect Dis J; 2013 Jul; 32(7):723-6. PubMed ID: 23838774
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predictors of shock and mortality in solid organ transplant recipients with bacteremia caused by non-lactose-fermenting gram-negative bacilli.
    Wan Q; Luo A; Ye Q; Liu S; Zhou J
    Infect Dis (Lond); 2016; 48(1):32-9. PubMed ID: 26329287
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bloodstream infections caused by antibiotic-resistant gram-negative bacilli: risk factors for mortality and impact of inappropriate initial antimicrobial therapy on outcome.
    Kang CI; Kim SH; Park WB; Lee KD; Kim HB; Kim EC; Oh MD; Choe KW
    Antimicrob Agents Chemother; 2005 Feb; 49(2):760-6. PubMed ID: 15673761
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative antimicrobial susceptibility of aerobic and facultative bacteria from community-acquired bacteremia to ertapenem in Taiwan.
    Lee SC; Huang SS; Lee CW; Fung CP; Lee N; Shieh WB; Siu LK
    BMC Infect Dis; 2007 Jul; 7():79. PubMed ID: 17640342
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multidrug resistant gram-negative bacilli as predominant bacteremic pathogens in liver transplant recipients.
    Shi SH; Kong HS; Xu J; Zhang WJ; Jia CK; Wang WL; Shen Y; Zhang M; Zheng SS
    Transpl Infect Dis; 2009 Oct; 11(5):405-12. PubMed ID: 19638006
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of adequate single-drug vs combination antimicrobial therapy on mortality in Pseudomonas aeruginosa bloodstream infections: a post Hoc analysis of a prospective cohort.
    Peña C; Suarez C; Ocampo-Sosa A; Murillas J; Almirante B; Pomar V; Aguilar M; Granados A; Calbo E; Rodríguez-Baño J; Rodríguez F; Tubau F; Oliver A; Martínez-Martínez L;
    Clin Infect Dis; 2013 Jul; 57(2):208-16. PubMed ID: 23580739
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Different impact of the appropriateness of empirical antibiotics for bacteremia among younger adults and the elderly in the ED.
    Lee CC; Chang CM; Hong MY; Hsu HC; Ko WC
    Am J Emerg Med; 2013 Feb; 31(2):282-90. PubMed ID: 23000336
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.